The drug "Cavinton forte"

The drug "Cavinton forte" as an active ingredient contains vinpocetine. The medication contributes to a significant improvement in the blood circulation of the brain and the rheological properties (fluidity) of the blood.

Round tablets "Cavinton" have a white (or almost white) color, do not have a smell. On one side there is an engraving "CAVINTON".

Medication "Cavinton" (tablets): instruction

The drug has a cerebroprotectiveimpact. The "Cavinton forte" agent can reduce the severity of cytotoxic reactions provoked by stimulating amino acids. The drug has a stimulating effect on brain metabolism, increases the absorption and absorption of oxygen and glucose by the brain.

Medication "Cavinton forte" increases blood flowselectively. The agent is able to strengthen the fraction of the brain of a minute volume, reduce the vascular resistance, without affecting the readings of the total blood circulation (minute volume, blood pressure, heart rate).

When using this medication, the blood supply to the affected (ischemic) but viable zone with low infusion (perfusion) occurs.

The drug is able to stimulate the cerebral metabolism (exchange) of serotonin and norepinephrine, to have an antioxidant effect.

The impact of Cavintonhypoxia mediated brain cells. It inhibits the aggregation of platelets, improves microcirculation of the brain, reduces the increased viscosity of blood of a pathological nature, increases the ability to deform red blood cells, blocking the absorption of adenosine by them.

In neurology, the use of the "Cavinton Fort"it is advisable in case of insufficient cerebral circulation in chronic and acute form (progressive stroke, transient ischemia, post-stroke conditions, atherosclerosis of vessels, vascular dementia, hypertensive and post-traumatic encephalopathy and others). The drug is also indicated for neurological and psychiatric disorders with cerebrovascular insufficiency (including dizziness, memory impairment, apraxia, headache, motor disorders).

In ophthalmology, the drug "Cavinton forte" is prescribed for vascular eye pathologies (angiospasm of the retina and vascular membrane, atherosclerosis, secondary glaucoma and others).

The drug is used for therapyENT diseases (with hearing loss of age, toxic or vascular genesis (origin)), Meniere's disease, tinnitus, as well as vasovegative manifestations of climacteric syndrome.

Contraindications to prescription of the drug"Cavinton forte" is lactation and pregnancy, heart failure in severe forms, as well as hypersensitivity to vinpocetine or ancillary components.

Dosage and duration of therapeuticcourse is appointed individually by a doctor. As a rule, it is enough to take the pill three times a day. Drink medication is recommended after a meal. The therapeutic course can last from one to eight months, usually an average of three to four months. When the drug is withdrawn, the dosage is reduced gradually over two to three days.

The use of the drug can provokeincreased manifestations of the existing arrhythmia. Sometimes dry mouth, weakness, heartburn, sleep disturbance, skin rash, nausea, headache, urticaria, skin hyperemia occur.

Cavinton does not have hepato- and nephrotoxic effects; therefore, when it is prescribed to patients who have hepatic or renal pathologies, dosage adjustment is not required.

The drug is not recommended for use in children under 18 years of age due to insufficient knowledge of the effect of its components on the child's body.